Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee
Современные достижения в диагностике, патофизиологии и лечении остеоартрита коленного сустава
2021-03-05
SCID: 54.1/vfaxb6fz
Discuss with AI
cartilage regenerationcell-based therapyclinical trialsknee osteoarthritismesenchymal stem cells
Figures from the paper
Abstract (AI)
Osteoarthritis (OA) is a degenerative and chronic joint disease characterized by clinical symptoms and distortion of joint tissues. It primarily damages joint cartilage, causing pain, swelling, and stiffness around the joint. It is the major cause of disability and pain. The prevalence of OA is expected to increase gradually with the aging population and increasing prevalence of obesity. Many potential therapeutic advances have been made in recent years due to the improved understanding of the underlying mechanisms, diagnosis, and management of OA. Embryonic stem cells and induced pluripotent stem cells differentiate into chondrocytes or mesenchymal stem cells (MSCs) and can be used as a source of injectable treatments in the OA joint cavity. MSCs are known to be the most studied cell therapy products in cell-based OA therapy owing to their ability to differentiate into chondrocytes and their immunomodulatory properties. They have the potential to improve cartilage recovery and ultimately restore healthy joints. However, despite currently available therapies and advances in research, unfulfilled medical needs persist for OA treatment. In this review, we focused on the contents of non-cellular and cellular therapies for OA, and briefly summarized the results of clinical trials for cell-based OA therapy to lay a solid application basis for clinical research.
Key Findings
1
Embryonic stem cells and induced pluripotent stem cells can generate chondrocytes or mesenchymal stem cells for potential intra-articular injectable therapies.
2
Improved understanding of OA mechanisms has driven recent advances in diagnosis and therapeutic development, but substantial unmet treatment needs remain.
3
Knee osteoarthritis is a chronic degenerative joint disease causing cartilage damage, pain, swelling, stiffness, disability, and substantial healthcare burden.
4
Mesenchymal stem cells are the most extensively studied cell-based OA therapy because of their chondrogenic differentiation and immunomodulatory properties, with potential to improve cartilage recovery and joint restoration.
5
OA prevalence is expected to rise with population aging and increasing obesity prevalence.
6
The review summarizes non-cellular and cellular treatments and clinical trial findings to support future clinical research on cell-based OA therapies.
Research Object
knee osteoarthritis and its affected joint tissues
Research Subject
recent updates in the diagnosis, pathophysiology, and treatment of knee osteoarthritis, including cellular and non-cellular therapies
Publication Details
Publication Date
2021-03-05
Journal
Publisher
ISSN
Cited by
807
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee2020
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee2020
Knee osteoarthritis: pathophysiology and current treatment modalities2018
Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration2020